Immunovant, Inc. (NASDAQ: IMVT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT IMMUNOVANT, INC.

Immunovant, Inc. (NASDAQ: IMVT)
Listen to this Section


$38.18
-0.0640 ( -0.17% ) 192.3K

Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).

Market Data


Open $38.18
Previous Close $38.24
Volume 192.3K
Market Cap $7.85B
Day Range $34.66 - $39.16
52 Week Range $14.32 - $39.28
Shares Outstanding 205.31M
Change % -0.17%
Net Change ▼ -0.0640
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Nov 10, 2025
10-q Quarterly Reports 58 Nov 10, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Oct 10, 2025
4 Insider transactions 1 Oct 10, 2025
8-k 8K-related 37 Sep 03, 2025
8-k 8K-related 12 Aug 28, 2025
8-k 8K-related 13 Aug 11, 2025
10-q Quarterly Reports 61 Aug 11, 2025

Latest News